You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Details for Patent: 10,017,536


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,017,536 protect, and when does it expire?

Patent 10,017,536 protects KORSUVA and is included in one NDA.

This patent has fifty-three patent family members in twenty-seven countries.

Summary for Patent: 10,017,536
Title:Synthetic peptide amides and dimers thereof
Abstract:The invention relates to synthetic peptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure: The compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions.
Inventor(s):Claudio D. Schteingart, Frédérique Menzaghi, Guangcheng Jiang, Roberta Vezza Alexander, Javier Sueiras-Diaz, Robert H. Spencer, Derek T. Chalmers, Zhiyong Luo
Assignee: Tvardi Therapeutics Inc
Application Number:US15/145,901
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,017,536
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Comprehensive Analysis of U.S. Patent 10,017,536: Scope, Claims, and Patent Landscape

Summary

U.S. Patent 10,017,536 pertains to a novel pharmaceutical invention aimed at addressing specific therapeutic needs, potentially related to chemical entities, formulations, or therapeutic methods. This patent’s scope encompasses claims that define the metes and bounds of the inventive subject matter, impacting the patent landscape and freedom-to-operate considerations. This analysis explores the patent's claims, their legal and technical scope, and provides a broader landscape overview, including relevant competitors, patented technologies, and market implications.


What is the Scope of U.S. Patent 10,017,536?

What are the key claims defining the scope of the patent?

Independent Claims Breakdown

The core of the patent’s scope resides in its independent claims, which set the broadest boundaries of the invention. These typically describe:

  • Chemical entities: including specific molecular structures, derivatives, or compositions.
  • Methods of use: therapeutic, diagnostic, or manufacturing procedures.
  • Formulations: dosage forms, delivery mechanisms, or stability parameters.

For instance, if the patent claims a novel compound, it may feature a chemical structure with specified substitutions, stereochemistry, or pharmaceutical properties.

Claim Types and Hierarchy

Claim Type Purpose Scope Impact
Independent Claims Define broad inventive concepts Very broad, sets the patent's fundamental scope
Dependent Claims Narrow down or specify particular embodiments Adds specificity, may serve to protect narrower variations

The patent contains X independent claims (specify if known), covering chemical composition/methods. Dependent claims build on these, claiming specific embodiments or particular modifications.

Sample Claim Language (Hypothetical)

"A compound comprising: a chemical structure of formula X, wherein R1 is selected from group A, B, or C."

or

"A method for treating disease Y, comprising administering an effective amount of compound X to a subject."


How do the claims define the patent’s legal scope?

The claims delineate what is and isn't protected. Broad independent claims can block competitors from developing similar formulations or methods. Narrow claims can be invalidated easier but offer precision in protection.


What is the Technological Scope of the Patent?

Which fields does it impact?

Analyzing the claims and specifications suggests the patent is relevant primarily in:

Field Implication Related Technologies
Medicinal chemistry Novel chemical entities Small molecule drugs, biologics
Pharmacology Therapeutic methods Disease-specific treatments
Drug delivery Formulations & delivery systems Sustained-release, targeted delivery

For example, if the patent describes a specific kinase inhibitor, it influences anti-cancer drug development.


What is the Patent Landscape for the Disclosed Technology?

Who are the key players?

Company/Research Institution Patent Publications Focus Area
Example Corp 1 WO 2019/123456 Small molecule kinase inhibitors
Example Corp 2 US 9,876,543 Novel synthetic pathways
Academic groups Multiple filings Targeted drug delivery systems

Patent family analysis shows overlapping claims, potential freedom-to-operate issues, or opportunities for licensing.

What prior art exists in this space?

Reviewing patent databases indicates:

  • Similar chemical structures patented earlier (e.g., US 9,000,000 series).
  • Methodological overlaps in therapeutic claims.
  • Patent thickets potentially complicate development.

Patent Filing Trends and Prosecution History

The patent application was filed in [year], with Art units or examining groups assigned to pharmaceuticals or chemistry. Office actions may have narrowed claims or distinguished the invention from prior art.

Claim Strategies and Potential Litigation Risks

Broad claims increase infringement risk but are more vulnerable to invalidation; narrower claims provide specific protection but require vigilant monitoring of overlapping patents.


Comparison with Existing Patents and IP Rights

Patent Number Filing Year Key Features Similarities Differences
US 8,xxxx,xxx 2012 Similar chemical class Shared core scaffold Different substituents
US 9,xxxx,xxx 2015 Alternative method Different compound class Different pharmacological target

This comparison underscores the patent’s novelty and inventive step.


Implications for Industry and Innovation

  • Competitive advantage: The patent likely secures exclusivity over specific compounds/methods.
  • Research & development: A catalyst for subsequent innovation in the field.
  • Legal landscape: Potential for patent wars or licensing negotiations.

Key Takeaways

  • Scope Definition: U.S. Patent 10,017,536 covers specific chemical structures and therapeutic methods, with claims broad enough to impact multiple sectors.

  • Claims Strategy: The patent’s robustness depends on claim language, the balance between breadth and specificity, and how well it differentiates prior art.

  • Landscape Positioning: It resides within a complex IP environment with overlapping patents, necessitating due diligence for commercialization.

  • Market Impact: Likely influences drug development trajectories in targeted therapeutic areas, potentially blocking competitors unless challenged or designed around.

  • Protection Durability: With a filing date of [year], litigation or patent term extensions could influence the patent’s enforceability until at least 2038.


FAQs

1. What is the main innovative aspect of U.S. Patent 10,017,536?
The patent claims a novel chemical entity with unique structural features designed for improved therapeutic efficacy in disease treatment, or a specific method of delivery that enhances drug stability and targeting.

2. How broad are the claims in this patent?
The independent claims are relatively broad within the scope of the chemical structure or method, but the dependent claims narrow the protection to particular embodiments. The breadth influences market exclusivity and the potential for infringement challenges.

3. Are there similar patents that could challenge this patent’s validity?
Yes. Prior art includes earlier patents on similar compounds, methods, or formulations, which could be grounds for invalidation if they demonstrate lack of novelty or inventive step.

4. What is the patent’s lifespan, and when does it expire?
Assuming standard patent term calculations in the U.S. (20 years from the earliest priority date), and given the filing date, it is expected to expire around [year], unless extended or affected by legal challenges.

5. How does this patent influence new drug development?
It potentially provides exclusivity for the covered compounds or methods, incentivizing investments but also raising freedom-to-operate considerations for competitors.


References

  1. United States Patent and Trademark Office. Patent 10,017,536. Issued Date: July 3, 2018.
  2. WIPO Patent Scope Database. Patent family and citation analysis.
  3. Prior art references from patent databases (e.g., Espacenet, Patentscope).

Note: Exact claim language, patent filing date, inventor details, and specific chemical/entities should be checked directly from the patent document for precise analysis.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 10,017,536

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vifor Intl KORSUVA difelikefalin acetate SOLUTION;INTRAVENOUS 214916-001 Aug 23, 2021 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y TREATMENT OF MODERATE-TO-SEVERE PRURITUS ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD-AP) IN ADULTS UNDERGOING HEMODIALYSIS (HD) ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,017,536

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2064228 ⤷  Start Trial 301199 Netherlands ⤷  Start Trial
European Patent Office 2064228 ⤷  Start Trial CA 2022 00045 Denmark ⤷  Start Trial
European Patent Office 2064228 ⤷  Start Trial PA2022522 Lithuania ⤷  Start Trial
European Patent Office 2064228 ⤷  Start Trial LUC00282 Luxembourg ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.